Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Alan Preiss, M.D., Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Stone AB, Dangerfield S, Preiss DA, Urman RD. Costs of Inaccurate Anesthesia Start Time Documentation Within a Health System. A A Pract. 2021 Feb 11; 15(2):e01404. PMID: 33577169.
    Citations:    Fields:    Translation:Humans
  2. Preiss D, Tobert JA, Hovingh GK, Reith C. Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar. J Am Coll Cardiol. 2020 04 28; 75(16):1945-1955. PMID: 32327106.
    Citations: 8     Fields:    Translation:Humans
  3. Schwartz GG, Leiter LA, Ballantyne CM, Barter PJ, Black DM, Kallend D, Laghrissi-Thode F, Leitersdorf E, McMurray JJV, Nicholls SJ, Olsson AG, Preiss D, Shah PK, Tardif JC, Kittelson J. Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease. Diabetes Care. 2020 05; 43(5):1077-1084. PMID: 32144166.
    Citations: 3     Fields:    Translation:Humans
  4. Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Køber L, Petrie MC, McMurray JJV. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019 10; 7(10):776-785. PMID: 31422062.
    Citations: 153     Fields:    Translation:Humans
  5. Morris DR, Sherliker P, Clack R, Preiss D, Lam KBH, Carter J, Halliday A, Peto R, Lewington S, Bulbulia R. Opposite Associations of Aortic Aneurysm With Blood Glucose and With Diabetes Mellitus. Circulation. 2019 07 16; 140(3):264-266. PMID: 31306072.
    Citations: 1     Fields:    Translation:Humans
  6. Welsh P, Preiss D, Hayward C, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Padmanabhan S, Welsh C, Woodward M, Campbell A, Porteous D, Mills NL, Sattar N. Cardiac Troponin T and Troponin I in the General Population. Circulation. 2019 06 11; 139(24):2754-2764. PMID: 31014085.
    Citations: 27     Fields:    Translation:Humans
  7. Rowland MJ, Urman RD, Xu X, Ehrenfeld JM, Preiss DA, Vacanti JC. The Impact of Airway Technique on Anesthesia Control Time. J Med Syst. 2019 Feb 11; 43(3):72. PMID: 30746553.
    Citations:    Fields:    Translation:Humans
  8. Armitage J, Holmes MV, Preiss D. Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 02 05; 73(4):477-487. PMID: 30704580.
    Citations: 31     Fields:    Translation:HumansAnimals
  9. Welsh P, Preiss D, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Hayward C, Padmanabhan S, Welsh C, Woodward M, Campbell A, Porteous D, Mills NL, Sattar N. Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort. Clin Chem. 2018 11; 64(11):1607-1616. PMID: 30126950.
    Citations: 18     Fields:    Translation:HumansPHPublic Health
  10. Herrington WG, Preiss D, Armitage J. Ezetimibe: Likely to Be Beneficial For All. Circulation. 2018 04 10; 137(15):1583-1584. PMID: 29632152.
    Citations:    Fields:    Translation:Humans
  11. Bouhenguel JT, Preiss DA, Urman RD. Implementation and Use of Anesthesia Information Management Systems for Non-operating Room Locations. Anesthesiol Clin. 2017 Dec; 35(4):583-590. PMID: 29101948.
    Citations:    Fields:    Translation:Humans
  12. Sattar N, Toth PP, Blom DJ, Koren MJ, Soran H, Uhart M, Elliott M, Cyrille M, Somaratne R, Preiss D. Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus. Am J Cardiol. 2017 Nov 01; 120(9):1521-1527. PMID: 28844508.
    Citations: 9     Fields:    Translation:Humans
  13. Sattar N, Preiss D. Reverse Causality in Cardiovascular Epidemiological Research: More Common Than Imagined? Circulation. 2017 06 13; 135(24):2369-2372. PMID: 28606949.
    Citations: 25     Fields:    Translation:Humans
  14. Toth PP, Descamps O, Genest J, Sattar N, Preiss D, Dent R, Djedjos C, Wu Y, Geller M, Uhart M, Somaratne R, Wasserman SM. Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies. Circulation. 2017 May 09; 135(19):1819-1831. PMID: 28249876.
    Citations: 12     Fields:    Translation:Humans
  15. Preiss D, Drew BA, Gosnell J, Kodali BS, Philip JH, Urman RD. Linshom thermodynamic sensor is a reliable alternative to capnography for monitoring respiratory rate. J Clin Monit Comput. 2018 Feb; 32(1):133-140. PMID: 28229352.
    Citations: 2     Fields:    Translation:Humans
  16. Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction). Circulation. 2017 Feb 21; 135(8):724-735. PMID: 28052977.
    Citations: 32     Fields:    Translation:Humans
  17. Preiss D, Mafham M. PCSK9 inhibition: the dawn of a new age in cholesterol lowering? Diabetologia. 2017 03; 60(3):381-389. PMID: 28025677.
    Citations: 5     Fields:    Translation:Humans
  18. Rankin NJ, Preiss D, Welsh P, Sattar N. Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future. Int J Epidemiol. 2016 10; 45(5):1351-1371. PMID: 27789671.
    Citations: 5     Fields:    Translation:HumansAnimals
  19. Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2016 09 08; 17(1):127. PMID: 27609359.
    Citations: 29     Fields:    Translation:Humans
  20. Brovman EY, Preiss D, Urman RD, Gross WL. The challenges of implementing electronic health records for anesthesia use outside the operating room. Curr Opin Anaesthesiol. 2016 Aug; 29(4):531-5. PMID: 27064215.
    Citations:    Fields:    Translation:Humans
  21. Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ. Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia. 2016 07; 59(7):1573-1574. PMID: 27174369.
    Citations: 2     Fields:    
  22. Sattar N, Preiss D. Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. Lancet Diabetes Endocrinol. 2016 07; 4(7):555-6. PMID: 27216887.
    Citations:    Fields:    Translation:Humans
  23. Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ. SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia. 2016 07; 59(7):1333-1339. PMID: 27112340.
    Citations: 73     Fields:    Translation:HumansAnimals
  24. Jackson CE, Haig C, Welsh P, Dalzell JR, Tsorlalis IK, McConnachie A, Preiss D, Anker SD, Sattar N, Petrie MC, Gardner RS, McMurray JJ. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. Eur J Heart Fail. 2016 12; 18(12):1491-1498. PMID: 27114189.
    Citations: 14     Fields:    Translation:Humans
  25. Sattar N, Preiss D. Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing. Lancet Diabetes Endocrinol. 2016 07; 4(7):560-2. PMID: 27039357.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  26. Nissen SE, Dent-Acosta RE, Rosenson RS, Stroes E, Sattar N, Preiss D, Mancini GB, Ballantyne CM, Catapano A, Gouni-Berthold I, Stein EA, Xue A, Wasserman SM, Scott R, Thompson PD. Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. Clin Cardiol. 2016 Mar; 39(3):137-44. PMID: 26946077.
    Citations: 12     Fields:    Translation:CTClinical Trials
  27. Sattar N, Preiss D, Robinson JG, Djedjos CS, Elliott M, Somaratne R, Wasserman SM, Raal FJ. Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data. Lancet Diabetes Endocrinol. 2016 05; 4(5):403-10. PMID: 26868195.
    Citations: 47     Fields:    Translation:Humans
  28. Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circ Heart Fail. 2016 Jan; 9(1). PMID: 26754626.
    Citations: 55     Fields:    Translation:Humans
  29. Loomis AK, Kabadi S, Preiss D, Hyde C, Bonato V, St Louis M, Desai J, Gill JM, Welsh P, Waterworth D, Sattar N. Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. J Clin Endocrinol Metab. 2016 Mar; 101(3):945-52. PMID: 26672639.
    Citations: 45     Fields:    Translation:Humans
  30. Welsh P, Hart C, Papacosta O, Preiss D, McConnachie A, Murray H, Ramsay S, Upton M, Watt G, Whincup P, Wannamethee G, Sattar N. Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment? Hypertension. 2016 Feb; 67(2):309-15. PMID: 26667414.
    Citations: 14     Fields:    Translation:Humans
  31. Goldie C, Taylor AJ, Nguyen P, McCoy C, Zhao XQ, Preiss D. Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials. Heart. 2016 Feb; 102(3):198-203. PMID: 26370223.
    Citations: 17     Fields:    Translation:Humans
  32. Preiss D, Thomas LE, Wojdyla DM, Haffner SM, Gill JM, Yates T, Davies MJ, Holman RR, McMurray JJ, Califf RM, Kraus WE. Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study. BMJ Open. 2015 Aug 14; 5(8):e007901. PMID: 26275900.
    Citations: 3     Fields:    Translation:Humans
  33. Rush CJ, Campbell RT, Jhund PS, Connolly EC, Preiss D, Gardner RS, Petrie MC, McMurray JJ. Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials. JACC Heart Fail. 2015 Aug; 3(8):603-14. PMID: 26251086.
    Citations: 10     Fields:    Translation:Humans
  34. Jackson CE, Haig C, Welsh P, Dalzell JR, Tsorlalis IK, McConnachie A, Preiss D, McInnes IB, Sattar N, Petrie MC, Gardner RS, McMurray JJ. Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure. JACC Heart Fail. 2015 Aug; 3(8):618-25. PMID: 26251088.
    Citations: 4     Fields:    Translation:Humans
  35. Preiss D, Neely D. Biochemistry laboratories should routinely report non-HDL-cholesterol. Ann Clin Biochem. 2015 Nov; 52(Pt 6):629-31. PMID: 26085052.
    Citations: 1     Fields:    Translation:Humans
  36. Yates T, Davies MJ, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Preiss D, Califf RM, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Kraus WE. Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial. Diabet Med. 2015 Aug; 32(8):1090-6. PMID: 25818859.
    Citations: 2     Fields:    Translation:Humans
  37. Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J. 2015 Jun 21; 36(24):1536-46. PMID: 25802390.
    Citations: 30     Fields:    Translation:HumansPHPublic Health
  38. Preiss D, Sattar N. Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA. 2015 Mar 10; 313(10):1016-7. PMID: 25756436.
    Citations: 6     Fields:    Translation:Humans
  39. Preiss D, Kristensen SL. The new pooled cohort equations risk calculator. Can J Cardiol. 2015 May; 31(5):613-9. PMID: 25843167.
    Citations: 21     Fields:    Translation:Humans
  40. Preiss D, Sattar N. Classification of reported statin intolerance. Curr Opin Lipidol. 2015 Feb; 26(1):65-6. PMID: 25551804.
    Citations: 1     Fields:    Translation:Humans
  41. Kristensen SL, Jhund PS, Køber L, Preiss D, Kjekshus J, McKelvie RS, Zile MR, Anand IS, Wikstrand J, Wedel H, Komajda M, Carson PE, Cleland JG, McMurray JJ. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. Eur J Heart Fail. 2015 Feb; 17(2):169-76. PMID: 25756844.
    Citations: 8     Fields:    Translation:Humans
  42. Preiss DA, Azami T, Urman RD. Variations in respiratory excretion of carbon dioxide can be used to calculate pulmonary blood flow. J Clin Med Res. 2015 Feb; 7(2):83-90. PMID: 25436024.
    Citations:    
  43. Welsh P, Preiss D, Lloyd SM, de Craen AJ, Jukema JW, Westendorp RG, Buckley BM, Kearney PM, Briggs A, Stott DJ, Ford I, Sattar N. Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia. 2014 Dec; 57(12):2513-20. PMID: 25264116.
    Citations: 8     Fields:    Translation:Humans
  44. Rankin NJ, Preiss D, Welsh P, Burgess KE, Nelson SM, Lawlor DA, Sattar N. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis. 2014 Nov; 237(1):287-300. PMID: 25299963.
    Citations: 18     Fields:    Translation:Humans
  45. Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D, Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJ, Lewsey JD, Chasman DI, Ridker PM, Maggioni AP, Tavazzi L, Ray KK, Seshasai SR, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Fornage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WM, Redline S, Patel SR, Whittaker JC, Hamsten A, Delaney JA, Dale C, Gaunt TR, Wong A, Kuh D, Hardy R, Kathiresan S, Castillo BA, van der Harst P, Brunner EJ, Tybjaerg-Hansen A, Marmot MG, Krauss RM, Tsai M, Coresh J, Hoogeveen RC, Psaty BM, Lange LA, Hakonarson H, Dudbridge F, Humphries SE, Talmud PJ, Kivimäki M, Timpson NJ, Langenberg C, Asselbergs FW, Voevoda M, Bobak M, Pikhart H, Wilson JG, Reiner AP, Keating BJ, Hingorani AD, Sattar N. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015 Jan 24; 385(9965):351-61. PMID: 25262344.
    Citations: 183     Fields:    Translation:Humans
  46. Preiss D. Do statins reduce microvascular complications in diabetes? Lancet Diabetes Endocrinol. 2014 Nov; 2(11):858-9. PMID: 25217179.
    Citations: 1     Fields:    Translation:Humans
  47. Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. BMJ. 2014 Jul 29; 349:g4596. PMID: 25239614.
    Citations: 80     Fields:    Translation:Humans
  48. Preiss D, Packard CJ. Emerging therapeutic approaches to treat dyslipidemia. Curr Cardiol Rep. 2014 Jul; 16(7):506. PMID: 24890766.
    Citations: 1     Fields:    Translation:Humans
  49. Preiss D, Haffner SM, Thomas LE, Sun JL, Sattar N, Yates T, J Davies M, McMurray JJ, Holman RR, Califf RM, Kraus WE. Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. Diabetes Obes Metab. 2014 Dec; 16(12):1265-8. PMID: 24861892.
    Citations: 1     Fields:    Translation:Humans
  50. Preiss D, McMurray JJ, Sattar N. Treatment of severe hypertriglyceridaemia. Lancet Diabetes Endocrinol. 2014 Nov; 2(11):860. PMID: 25439459.
    Citations:    Fields:    Translation:HumansAnimals
  51. Preiss D, Sattar N. Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Curr Opin Lipidol. 2013 Dec; 24(6):532-3. PMID: 24231280.
    Citations: 1     Fields:    Translation:Humans
  52. Preiss D, Lloyd SM, Ford I, McMurray JJ, Holman RR, Welsh P, Fisher M, Packard CJ, Sattar N. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014 Feb; 2(2):116-24. PMID: 24622715.
    Citations: 51     Fields:    Translation:Humans
  53. Preiss D, Giles TD, Thomas LE, Sun JL, Haffner SM, Holman RR, Standl E, Mazzone T, Rutten GE, Tognoni G, Chiang FT, McMurray JJ, Califf RM. Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. Stroke. 2013 Sep; 44(9):2590-3. PMID: 23899915.
    Citations: 2     Fields:    Translation:Humans
  54. Perez AC, Jhund P, Preiss D, Kjekshus J, McMurray JJ. Effect of rosuvastatin on fatigue in patients with heart failure. J Am Coll Cardiol. 2013 Mar 12; 61(10):1121-2. PMID: 23473415.
    Citations: 4     Fields:    Translation:Humans
  55. Preiss D, Thomas LE, Sun JL, Haffner SM, Holman RR, Standl E, Leiter LA, Mazzone T, Rutten GE, Tognoni G, Martinez FA, Chiang FT, Califf RM, McMurray JJ. Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open. 2012; 2(6). PMID: 23204139.
    Citations: 5     Fields:    
  56. Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJ. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA. 2012 Aug 22; 308(8):804-11. PMID: 22910758.
    Citations: 34     Fields:    Translation:Humans
  57. Preiss D, van Veldhuisen DJ, Sattar N, Krum H, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ. Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2012 Aug; 14(8):909-15. PMID: 22611047.
    Citations: 14     Fields:    Translation:Humans
  58. Sattar N, Preiss D. HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia. 2012 Jun; 55(6):1564-7. PMID: 22398646.
    Citations: 6     Fields:    Translation:Humans
  59. Preiss D, Sattar N. Statins and the risk of new-onset diabetes: a review of recent evidence. Curr Opin Lipidol. 2011 Dec; 22(6):460-6. PMID: 21897230.
    Citations: 29     Fields:    Translation:HumansAnimals
  60. Ford I, Mooijaart SP, Lloyd S, Murray HM, Westendorp RG, de Craen AJ, Packard CJ, Buckley B, Barlow C, Preiss D, Cobbe SM, Stott DJ, Sattar N. The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol. 2011 Dec; 40(6):1530-8. PMID: 22158663.
    Citations: 16     Fields:    Translation:Humans
  61. Preiss D, Sattar N. The case for diabetes screening: ADDITION-Europe. Lancet. 2011 Jul 09; 378(9786):106-8. PMID: 21705070.
    Citations:    Fields:    Translation:HumansPHPublic Health
  62. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011 Jun 22; 305(24):2556-64. PMID: 21693744.
    Citations: 353     Fields:    Translation:Humans
  63. Preiss D, Sattar N, McMurray JJ. A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. Am Heart J. 2011 Jan; 161(1):210-219.e1. PMID: 21167356.
    Citations: 9     Fields:    Translation:Humans
  64. Preiss D, Khunti K, Sattar N. Combined cardiovascular and diabetes risk assessment in primary care. Diabet Med. 2011 Jan; 28(1):19-22. PMID: 21210538.
    Citations: 7     Fields:    Translation:Humans
  65. Preiss D, Sattar N. HbA1c: a useful cardiovascular risk marker in those without diabetes? Diabetologia. 2010 Dec; 53(12):2468-9. PMID: 20835700.
    Citations:    Fields:    Translation:Humans
  66. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology. 2010 Sep; 52(3):1156-61. PMID: 20658466.
    Citations: 72     Fields:    Translation:Humans
  67. Preiss D, Sattar N, McMurray JJ. Event rates in trials of patients with type 2 diabetes. JAMA. 2010 Feb 24; 303(8):732-3; author reply 733. PMID: 20179281.
    Citations: 1     Fields:    Translation:Humans
  68. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010 Feb 27; 375(9716):735-42. PMID: 20167359.
    Citations: 613     Fields:    Translation:Humans
  69. Balaban DY, Regan R, Mardimae A, Slessarev M, Han JS, Wells GD, Duffin J, Iscoe S, Fisher JA, Preiss D. A simple and portable breathing circuit designed for ventilatory muscle endurance training (VMET). Respir Med. 2009 Dec; 103(12):1822-7. PMID: 19679458.
    Citations:    Fields:    Translation:Humans
  70. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009 May 23; 373(9677):1765-72. PMID: 19465231.
    Citations: 352     Fields:    Translation:Humans
  71. Preiss D, Sattar N. Metabolic syndrome: collapsing under its own weight? Diabet Med. 2009 May; 26(5):457-9. PMID: 19646182.
    Citations: 5     Fields:    Translation:Humans
  72. Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care. 2009 May; 32(5):915-20. PMID: 19196892.
    Citations: 14     Fields:    Translation:Humans
  73. Preiss D, Sattar N. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol (Oxf). 2009 Jun; 70(6):815-28. PMID: 19067719.
    Citations: 15     Fields:    Translation:HumansAnimals
  74. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008 Sep; 115(5):141-50. PMID: 18662168.
    Citations: 71     Fields:    Translation:Humans
  75. Preiss D, Fisher J. A measure of confidence in Bland-Altman analysis for the interchangeability of two methods of measurement. J Clin Monit Comput. 2008 Aug; 22(4):257-9. PMID: 18607545.
    Citations: 7     Fields:    
  76. Somogyi RB, Vesely AE, Preiss D, Prisman E, Volgyesi G, Azami T, Iscoe S, Fisher JA, Sasano H. Precise control of end-tidal carbon dioxide levels using sequential rebreathing circuits. Anaesth Intensive Care. 2005 Dec; 33(6):726-32. PMID: 16398376.
    Citations: 16     Fields:    Translation:Humans
  77. Simchen MJ, Tesler J, Azami T, Preiss D, Fedorko L, Goldszmidz E, Fisher J, Kingdom J, Slorach C, Hornberger LK. Effects of maternal hyperoxia with and without normocapnia in uteroplacental and fetal Doppler studies. Ultrasound Obstet Gynecol. 2005 Oct; 26(5):495-9. PMID: 16180259.
    Citations: 8     Fields:    Translation:Humans
  78. Azami T, Preiss D, Somogyi R, Vesely A, Prisman E, Iscoe S, De Wolf AM, Fisher JA. Calculation of O2 consumption during low-flow anesthesia from tidal gas concentrations, flowmeter, and minute ventilation. J Clin Monit Comput. 2004 Dec; 18(5-6):325-32. PMID: 15957623.
    Citations: 1     Fields:    Translation:Humans
  79. Somogyi R, Vesely AE, Azami T, Preiss D, Fisher J, Correia J, Fowler RA. Dispersal of respiratory droplets with open vs closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome. Chest. 2004 Mar; 125(3):1155-7. PMID: 15006983.
    Citations: 18     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Preiss's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (282)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.